Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 314 participants.
Also called NCT07717216
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 314 participants
- Sponsor
- Weifang Medical University
- Registry
-
NCT07717216
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07717216. Randomized; triple masking; primary purpose treatment. Start 2026-09-01 (anticipated); primary completion 2029-09-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND)
- Condition
- Stroke, Acute
- Condition
- Neuroprotection
- Condition
- Normobaric Hyperoxia
- Condition
- Endovascular Treatment
- Intervention (Drug)
- Oxygen (Normobaric Hyperoxia)
- Intervention (Drug)
- Sham Normobaric Hyperoxia
- Intervention (Procedure)
- Endovascular Therapy
- Lead sponsor
- Weifang Medical University
Record details
- Record id
cardio:ct-nct07717216- Content hash
886edbcbf653c01d7aac492bffd29646100a0a9931e4bc1e0cd117a159faf846